Temodar Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Condition:   Melanoma Intervention:   Drug: Fluzoparib Camrelizumab Temozolomide Sponsor:   Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Condition:   Melanoma Intervention:   Drug: Fluzoparib Camrelizumab Temozolomide Sponsor:   Jun Guo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Conditions:   Glioblastoma;   Recurrent Glioblastoma;   GBM Interventions:   Device: SonoCloud-9 (SC9);   Drug: Carboplatin;   Drug: Lomustine;   Drug: Temozolomide Sponsor:   CarThera Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2023 Category: Research Source Type: clinical trials